SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-18-003378
Filing Date
2018-03-15
Accepted
2018-03-15 07:15:28
Documents
7
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 17293
2 ex99-1.htm EX-99.1 78840
3 ex99-1_001.jpg GRAPHIC 3989
4 ex99-1_002.jpg GRAPHIC 3989
5 ex99-1_003.jpg GRAPHIC 3989
6 ex99-1_004.jpg GRAPHIC 3989
7 ex99-1_005.jpg GRAPHIC 3989
  Complete submission text file 0001493152-18-003378.txt   125166
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 18691046
SIC: 2834 Pharmaceutical Preparations